Related Experiment Video
Updated: Jun 26, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Overlooked cases of mild cognitive impairment: Implications to early Alzheimer's disease
Maamoon Mian1, Jihane Tahiri2, Ryan Eldin3
1Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.
Abstract:
Mild cognitive impairment (MCI) marks the initial phase of memory decline or other cognitive functions like language or spatial perception, while individuals typically retain the capacity to carry out everyday tasks independently. Our comprehensive article investigates the intricate landscape of cognitive disorders, focusing on MCI and Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD). The study aims to understand the signs of MCI, early Alzheimer's disease, and healthy brain aging while assessing factors influencing disease progression, pathology development and susceptibility. A systematic literature review of over 100 articles was conducted, emphasizing MCI, AD and ADRD within the elderly populations. The synthesis of results reveals significant findings regarding ethnicity, gender, lifestyle, comorbidities, and diagnostic tools. Ethnicity was found to influence MCI prevalence, with disparities observed across diverse populations. Gender differences were evident in cognitive performance and decline, highlighting the need for personalized management strategies. Lifestyle factors and comorbidities were identified as crucial influencers of cognitive health. Regarding diagnostic tools, the Montreal Cognitive Assessment (MoCA) emerged as superior to the Mini-Mental State Examination (MMSE) in early MCI detection. Overall, our article provides insights into the multifaceted nature of cognitive disorders, emphasizing the importance of tailored interventions and comprehensive assessment strategies for effective cognitive health management.
Insights
Mild cognitive impairment (MCI) and Alzheimer's disease (AD) impact the elderly. The Montreal Cognitive Assessment (MoCA) shows promise for early detection, outperforming the Mini-Mental State Examination (MMSE).
Area of Science:
- Gerontology and Neurology
- Cognitive Disorders Research
Background:
- Mild cognitive impairment (MCI) represents an early stage of cognitive decline, distinct from healthy aging, impacting functions like memory, language, and spatial perception.
- Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD) are progressive neurodegenerative conditions significantly affecting the elderly population.
Purpose of the Study:
- To investigate the signs of MCI, early AD, and healthy brain aging.
- To assess factors influencing cognitive disorder progression, pathology development, and susceptibility.
- To compare diagnostic tools for early detection of cognitive impairment.
Main Methods:
- A systematic literature review of over 100 articles was conducted.
- Focus was placed on studies concerning MCI, AD, and ADRD in elderly populations.
- Analysis included factors such as ethnicity, gender, lifestyle, comorbidities, and diagnostic efficacy.
Main Results:
- Ethnicity influences MCI prevalence, with observed disparities among diverse populations.
- Gender differences impact cognitive performance and decline rates.
- Lifestyle factors and comorbidities significantly affect cognitive health.
- The Montreal Cognitive Assessment (MoCA) demonstrates superior efficacy over the Mini-Mental State Examination (MMSE) for early MCI detection.
Conclusions:
- Cognitive disorders are multifaceted, influenced by a complex interplay of demographic, lifestyle, and clinical factors.
- Personalized management strategies are essential, considering ethnic and gender variations.
- The MoCA is a more sensitive tool for identifying early-stage MCI, aiding timely intervention.
More Related Videos
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
06:58Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Dementia
The progression of dementia is generally gradual....
Cognitive Development During Adulthood
Alzheimer's Disease: Treatment
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Language and Cognition